BLAIR WILLIAM & CO/IL - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 60 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$75,691
-65.8%
51,8430.0%0.00%
-100.0%
Q3 2022$221,000
+10.0%
51,8430.0%0.00%0.0%
Q2 2022$201,000
-18.6%
51,8430.0%0.00%0.0%
Q1 2022$247,000
+30.7%
51,8430.0%0.00%0.0%
Q4 2021$189,000
-54.6%
51,8430.0%0.00%0.0%
Q3 2021$416,000
-29.3%
51,8430.0%0.00%
-50.0%
Q2 2021$588,000
+22.5%
51,8430.0%0.00%0.0%
Q1 2021$480,00051,8430.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,120,0000.80%
Samsara BioCapital, LLC 689,709$2,676,0000.71%
BVF INC/IL 3,614,662$14,025,0000.68%
HAMILTON LANE ADVISORS LLC 71,491$277,0000.11%
MAI Capital Management 647,950$2,514,0000.05%
Laurion Capital Management LP 698,000$2,708,0000.04%
Jasper Ridge Partners, L.P. 92,939$361,0000.02%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$80,0000.02%
Ergoteles LLC 155,562$604,0000.02%
Clear Harbor Asset Management, LLC 25,000$97,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders